BIONOMICS INC has a total of 42 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are IMMUNGENE INC, TECHNOPHARM and ACTICOR BIOTECH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Australia | 8 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | WIPO (World Intellectual Property Organization) | 7 | |
#5 | China | 3 | |
#6 | Canada | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Hong Kong | 1 | |
#9 | Mexico | 1 | |
#10 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Chu Peter | 41 |
#2 | Reyes Christopher L | 33 |
#3 | Tan Xiangyang | 21 |
#4 | Graff Christilyn | 21 |
#5 | Yang Weixing | 21 |
#6 | Smith Kristen M | 14 |
#7 | Campbell Lioudmila A | 11 |
#8 | Norton John Thomas | 10 |
#9 | Shojaei Farbod | 10 |
#10 | Reyes Christopher | 7 |
Publication | Filing date | Title |
---|---|---|
WO2015200073A1 | Antibodies that bind lgr4 | |
AU2015240599A1 | Humanized antibodies that bind LGR5 | |
US2015037324A1 | Methods of inhibiting solid tumor growth by administering GPR49 antibodies | |
EP2773373A1 | Methods of blocking cancer stem cell growth | |
AU2012332590A1 | Anti-GPR49 antibodies | |
US2014302049A1 | Anti-GPR49 monoclonal antibodies |